ENTITY

SMARTSCORE: 3.2/5

Scivision Biotech (1786 TT)

Health Care • Taiwan

Scivision Biotech Inc produces medical Hyaluronic Acid using fermentation biotechnology. The company products include Hya-Dermis and Hya-Joint injection, skin care series and health food.

more

Refresh

Exchange Announcement • 24 Jun 2025 09:07

The Company Makes Application To Extend Three Months For Raising Funds Of Issuing The Third Domestic Unsecured Convertible Corporate Bond Approved By The Fsc

Exchange Announcement • 20 Jun 2025 08:22

The Company Makes The Application To Extend Three Months For Raising Funds Of Issuing The Third Domestic Unsecured Convertible Corporate Bond.

Exchange Announcement • 22 May 2025 08:43

The Company Has Received Notice Of Allowance For A Patent From Japan Office For Method Of Manufacturing Auto-Crosslinked Hyaluronic Acid Gel And Products Thereof

Exchange Announcement • 16 May 2025 09:42

The Company'S Products,1 And 3-Injection Type Hyaluron Synovial Fluid Supplement"Flexvisc","Jetknee", And"Flexvisc Plus" Have Obtained Medical Device Licenses.

Exchange Announcement • 08 May 2025 08:02

To Announce The Record Date Of Common Stocks Transferred From The 2nd Domestic Unsecured Convertible Bond For The First Quarter Of 2025

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.6

x